Genmab A/S(DE:GE9)
€478.10-1.20 (-0.25%)
DE:GE9
Genmab A/S ownership
€478.10
At close:-1.20 (-0.25%)
Genmab A/S (GE9) Ownership - Who Owns Genmab A/S?
15 Followers
Genmab A/S (GE9) Ownership Overview
- 10.82% Mutual Funds
- 0.35% Other Institutional Investors
- 12.60% ETFs
- 76.23% Public Companies and Individual Investors
The ownership structure of Genmab A/S (DE:GE9) stock is a mix of institutional, retail, and individual investors. Approximately 23.77% of the company’s stock is owned by Institutional Investors, and 76.23% is owned by Public Companies and Individual Investors.
The ownership structure of Genmab A/S (DE:GE9) stock is a mix of institutional, retail, and individual investors. Approximately 23.77% of the company’s stock is owned by Institutional Investors, and 76.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 2,290,957 | Institution | 3.67% | 1,215,414,544 |
| Vanguard | 2,094,942 | Institution | 3.36% | 1,111,423,294 |
| Vanguard Specialized Funds | 1,278,865 | Institution | 2.05% | 678,472,412 |
| Vanguard Star Funds | 882,718 | Institution | 1.41% | 468,305,732 |
| Amundi | 873,344 | Institution | 1.40% | 463,332,572 |
| Ubs | 692,185 | Institution | 1.11% | 367,222,831 |
| Vanguard World Fund | 615,416 | Institution | 0.99% | 326,494,804 |
| Vanguard Tax-managed Funds | 582,477 | Institution | 0.93% | 309,019,775 |
| Xtrackers | 570,372 | Institution | 0.91% | 302,597,746 |
| Harding Loevner Funds Inc | 471,810 | Institution | 0.76% | 250,307,944 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 1,278,865 | Institution | 2.05% | 678,472,412 |
| Vanguard Star Funds | 882,718 | Institution | 1.41% | 468,305,732 |
| Vanguard World Fund | 615,416 | Institution | 0.99% | 326,494,804 |
| Vanguard Tax-managed Funds | 582,477 | Institution | 0.93% | 309,019,775 |
| Harding Loevner Funds Inc | 471,810 | Institution | 0.76% | 250,307,944 |
| Vanguard International Equity Index Funds | 338,788 | Institution | 0.54% | 179,736,181 |
| Baird Funds Inc | 314,059 | Institution | 0.50% | 166,616,779 |
| Artisan Partners Funds Inc. | 276,490 | Institution | 0.44% | 146,685,410 |
| Fidelity Concord Street Trust | 260,545 | Institution | 0.42% | 138,226,157 |
| Fidelity Salem Street Trust | 224,158 | Institution | 0.36% | 118,921,871 |
FAQ
What percentage of Genmab A/S (DE:GE9) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.77% of Genmab A/S (DE:GE9) stock is held by institutional investors: 10.82% by mutual funds, 12.60% by ETFs and 0.35% by other institutional investors.
What percentage of Genmab A/S (DE:GE9) stock is held by retail investors?
According to the latest TipRanks data, approximately 76.23% of Genmab A/S (DE:GE9) stock is held by public companies and individual investors.
Who owns the most shares of Genmab A/S (DE:GE9)?
iShares owns the most shares of Genmab A/S (DE:GE9).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
